KINDLER JEFFREY B 4
Research Summary
AI-generated summary
Precigen (PGEN) Director Jeffrey Kindler Receives Award
What Happened Jeffrey B. Kindler, a director of Precigen, was granted stock as compensation on March 10, 2026. He was issued 19,658 common shares (valued at $3.51 each, total $69,000) in lieu of his annual retainer, plus two restricted stock unit (RSU) awards totaling 76,685 RSUs (35,612 and 41,073 RSUs). The 19,658 shares are delivered now; the RSUs are derivative awards that represent contingent rights to receive common stock in the future.
Key Details
- Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (timely within the two‑business‑day window).
- Grants: 19,658 common shares acquired at $3.51/share (cash value $69,000); 35,612 RSUs and 41,073 RSUs granted at $0 (derivative awards).
- RSU terms: Each RSU equals one contingent share; all RSUs vest in full on March 10, 2027 (Footnotes F2, F3).
- Reason: 19,658 shares issued in lieu of the director’s $69,000 annual retainer (Footnote F1).
- Shares owned after transaction: Not specified in the filing.
Context
- These entries are awards/compensation (transaction code A), not open‑market purchases or sales. Awards are common for director compensation and do not by themselves indicate buying or selling sentiment.
- RSUs are derivative grants that convert to actual shares only upon vesting (here, on 3/10/2027); no immediate sale or option exercise was reported.